HALO logo
halo search icon
Altimmune, Inc.

US$2.82

Price Change Indicator
0.08 (2.92%)
Altimmune, Inc.
ALT · NAS

Altimmune, Inc.

Start Trading ALT for Free

US$2.82

Price Arrow0.08 (2.92%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueHALO Earnings MomentumRecent Earnings upgradeRecent Price downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Altimmune, Inc. Overview

ALT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ALT

icon
icon

Telephone

1.240.654.1450

icon

Address

Suite 201S, 910 Clopper Road, Gaithersburg, MD 20878

Description

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

ALT Price Chart

Key Stats

Market Cap

US$532.86M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.56 - 7.73

Trade Value (12mth)

US$4,582,880.00

1 week

-3.86%

1 month

-19.65%

YTD

-21.94%

1 year

-50.98%

All time high

2724.00

Key Fundamentals

EPS 3 yr Growth

-44.60%

EBITDA Margin

NaN%

Operating Cashflow

-$68m

Free Cash Flow Return

-35.10%

ROIC

-45.70%

Interest Coverage

-57.70

Quick Ratio

18.50

Other Data

Shares Outstanding (Fully Diluted)

124m

HALO Sector

Healthcare

Next Company Report Date

03-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ALT Announcements

Latest Announcements

DateAnnouncements
14 May 26
13 May 26
13 May 26
29 April 26
25 April 26

ALT Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.66-1.34-1locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.66-1.34-1locklocklock
Growth
 %locklocklocklock819.425.3locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Altimmune, Inc. (ALT:NAS)?
Halo FAQ
The current share price of Altimmune, Inc. (ALT:NAS) is USD$2.82.
What is the 52-week high share price for Altimmune, Inc. (ALT:NAS)?
Halo FAQ
The 52-week high share price for Altimmune, Inc. (ALT:NAS) is USD$7.73.
What is the 52-week low share price for Altimmune, Inc. (ALT:NAS)?
Halo FAQ
The 52-week low share price for Altimmune, Inc. (ALT:NAS) is USD$2.56.
What is the dividend yield for Altimmune, Inc. (ALT:NAS)?
Halo FAQ
Altimmune, Inc. (ALT:NAS) does not pay a dividend.
What was Altimmune, Inc. (ALT:NAS) last dividend payment?
Halo FAQ
The last dividend payment of Altimmune, Inc. (ALT:NAS) is USD$2.91.
What is the franking level for Altimmune, Inc. (ALT:NAS)?
Halo FAQ
Altimmune, Inc. (ALT:NAS) has a franking level of 0.00%.
In which sector is Altimmune, Inc. (ALT:NAS) classified?
Halo FAQ
Altimmune, Inc. (ALT:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial